UBS Group AG - BONE BIOLOGICS CORP ownership

BONE BIOLOGICS CORP's ticker is and the CUSIP is 098070113. A total of 6 filers reported holding BONE BIOLOGICS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BONE BIOLOGICS CORP
ValueSharesWeighting
Q1 2023$10250
-94.2%
0.00%
Q3 2022$0
-100.0%
4,3010.0%0.00%
Q2 2022$1,000
-75.0%
4,301
-60.5%
0.00%
Q1 2022$4,000
+33.3%
10,893
+136.8%
0.00%
Q4 2021$3,0004,6010.00%
Other shareholders
BONE BIOLOGICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Empery Asset Management, LP 140,471$48,0000.23%
SABBY MANAGEMENT, LLC 108,476$37,0000.01%
CLEAR STREET LLC 20,000$7,0000.00%
Warberg Asset Management LLC 219,134$76,0000.00%
UBS Group AG 10,893$4,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BONE BIOLOGICS CORP shareholders